-
Forward Look
A Global Perspective on CancerQ&A with Christopher P. Wild on World Cancer Report 2014.
by Sue Rochman
-
Forward Look
Efforts Underway to Raise the Legal Age to Buy TobaccoLocal laws strive to reduce the number of new smokers.
by Melissa Weber
-
Forward Look
FDA Proposes Action on E-CigarettesResearch into the safety of the new device continues.
by Sue Rochman
-
-
Survivor Profile
Knowing Her OptionsWhen Christina McEvoy was diagnosed with stage IV melanoma, she took the reins of her care, traveling more than 600 miles for treatment and returning home to help other melanoma survivors.
by Melissa Davlin
-
Get Involved
Taking the Chill Out of ChemoTeenager starts Get Cozy During Chemo to provide blankets for cancer patients in treatment.
by Leigh Zaleski
-
Editor's Letter
The Promise of ImmunotherapyImmunotherapy is a breakthrough in cancer treatment, but more research is needed to broaden its impact.
by Kevin McLaughlin
-
Forward Look
Affordable Care Act to Cover Breast Cancer Risk Reduction DrugsMedications are an option for high-risk women, but few use them.
by Sue Rochman
-
Forward Look
Push Needed to Increase HPV Vaccination RatesPresident's Cancer Panel stresses reducing 'missed opportunities.'
by Sue Rochman
-
Forward Look
Moving Closer to a Menthol Ban?FDA weighs whether to prohibit sales of mentholated tobacco products.
by Sharon Reynolds
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
